Viewing Study NCT01325558


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-02-21 @ 9:48 PM
Study NCT ID: NCT01325558
Status: COMPLETED
Last Update Posted: 2016-07-15
First Post: 2011-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Sponsor: Altor BioScience
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Malignant Neoplasm View
None Malignant Solid Tumour View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None tissue factor View
None solid tumor View
None ovarian cancer View
None breast cancer View
None non-small cell lung cancer View
None colon cancer View
None pancreatic cancer View
None head and neck cancer View
None prostate cancer View
None soft-tissue sarcoma View
None metastatic View
None gemcitabine View
None anti-tumor View
None venous thromboembolism View